Parallel Contract

A Parallel Contract is a procurement arrangement where the government awards concurrent contracts to two or more suppliers or contractors for the same category of goods or services, and places individual orders among them according to pre-defined distribution rules, typically L1 first, with L2 and L3 as fallbacks if L1 cannot supply. Parallel contracting is used when a single source carries too much supply risk (especially for critical goods), when the required volume exceeds the capacity of any single supplier, or when geographic distribution of work requires multiple executing entities. It differs from a rate running contract with multiple empanelled vendors in that each parallel contract is a formal award, not merely an empanelment.

What is a Parallel Contract in government procurement?

Under the standard government procurement framework, only the L1 bidder wins the contract. However, for certain categories, particularly critical medical supplies, pharmaceutical items, petroleum products, and high-volume construction materials, depending entirely on a single L1 supplier creates a supply security risk. If the L1 supplier fails, the buyer faces an immediate shortage and must resort to risk purchase at higher prices. To mitigate this, some government buyers, particularly defence establishments, hospitals, railway stores depots, and large PSUs, award parallel contracts to L1, L2, and sometimes L3 bidders simultaneously.

The typical parallel contract structure for a three-way parallel award is: L1 receives 50% of orders, L2 receives 30%, and L3 receives 20%. Orders are distributed proportionally as the requirement arises. Alternatively, L1 is given the first right of refusal on each order, only if L1 cannot supply within the required delivery period does the order go to L2, and similarly to L3. In the first model, each supplier knows its guaranteed share; in the second, L2 and L3 supply only when L1 fails.

Parallel contracts are particularly common in pharmaceutical procurement. Central government hospitals and state medical supply corporations procure medicines through parallel contracts to multiple manufacturers for each essential medicine, because supply security of life-saving drugs is critical and single-source supply is unacceptable even at the L1 price.

CVC guidelines require that when parallel contracts are awarded, the L2 and L3 prices are within a reasonable band of the L1 price, not dramatically higher, to ensure value for money. Parallel contracting should not become a route to routinely paying L2 or L3 prices when L1 is fully capable of supplying.

Why it matters for bidders

For L1 bidders, parallel contracting means that even after winning on price, they must perform reliably to retain their order share, failure to deliver means orders divert to L2 or L3, and repeated failures can lead to the parallel contract being restructured to give L2 the primary share.

For L2 and L3 bidders, parallel contracting is an opportunity that does not exist in standard L1-winner-takes-all procurement. If your price is slightly above L1 but you are confident in your supply capability, submitting a competitive bid and securing an L2 or L3 parallel contract award gives you guaranteed government business at a modest price premium over L1. This is particularly valuable in pharmaceutical manufacturing, where factory capacity utilisation matters, a government parallel contract provides base-load utilisation.

The parallel contract structure also creates incentive for L1 to maintain supply discipline. Knowing that L2 is ready and capable, L1 has less room to delay deliveries without consequence.

Example

A central government general hospital invites tenders for supply of Paracetamol 500 mg tablets for the coming financial year, estimated requirement of 20 lakh tablets. The NIT specifies a parallel contract structure: awards will be made to L1, L2, and L3 if all are within 10% of L1's price, with distribution: L1 = 50%, L2 = 30%, L3 = 20%. L1 bids Rs 0.85/tablet, L2 bids Rs 0.88/tablet, and L3 bids Rs 0.91/tablet, all within 10% of L1. All three are awarded parallel contracts. Monthly supply orders are placed: L1 receives 5 lakh tablets per order cycle, L2 receives 3 lakh, and L3 receives 2 lakh. If in month 4 L1 is unable to supply its full share, the deficit is placed with L2.

Key rules / thresholds

• Parallel contracting must be specified in the original NIT, it cannot be introduced after bid opening.
• L2 and L3 prices in a parallel contract must typically be within a specified band of L1 (often 10-15%) for all three to be included.
• CVC guidelines: parallel contracting is acceptable for supply security reasons but must not become a routine way to pay above-L1 prices.
• Order distribution rules must be written into the contract, not left to the buyer's discretion, to avoid arbitrary allocation favouring a non-L1 supplier.